Logo image of CYBR

CYBERARK SOFTWARE LTD/ISRAEL (CYBR) Stock Fundamental Analysis

NASDAQ:CYBR - Nasdaq - IL0011334468 - Common Stock - Currency: USD

405.04  -3.96 (-0.97%)

Premarket: 405.04 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CYBR. CYBR was compared to 282 industry peers in the Software industry. CYBR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CYBR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CYBR had positive earnings in the past year.
CYBR had a positive operating cash flow in the past year.
CYBR had negative earnings in each of the past 5 years.
CYBR had a positive operating cash flow in each of the past 5 years.
CYBR Yearly Net Income VS EBIT VS OCF VS FCFCYBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

CYBR has a Return On Assets (-3.65%) which is comparable to the rest of the industry.
The Return On Equity of CYBR (-7.13%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.65%
ROE -7.13%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-3.71%
ROE(3y)-10.52%
ROE(5y)-8.79%
ROIC(3y)N/A
ROIC(5y)N/A
CYBR Yearly ROA, ROE, ROICCYBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

CYBR has a Gross Margin of 76.86%. This is in the better half of the industry: CYBR outperforms 73.40% of its industry peers.
In the last couple of years the Gross Margin of CYBR has declined.
CYBR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-1.54%
CYBR Yearly Profit, Operating, Gross MarginsCYBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

CYBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CYBR has been increased compared to 1 year ago.
The number of shares outstanding for CYBR has been increased compared to 5 years ago.
There is no outstanding debt for CYBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CYBR Yearly Shares OutstandingCYBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CYBR Yearly Total Debt VS Total AssetsCYBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 5.94 indicates that CYBR is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.94, CYBR is doing good in the industry, outperforming 73.05% of the companies in the same industry.
CYBR has a debt to FCF ratio of 5.88. This is a neutral value as CYBR would need 5.88 years to pay back of all of its debts.
CYBR has a Debt to FCF ratio (5.88) which is in line with its industry peers.
CYBR has a Debt/Equity ratio of 0.53. This is a neutral value indicating CYBR is somewhat dependend on debt financing.
The Debt to Equity ratio of CYBR (0.53) is worse than 66.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.88
Altman-Z 5.94
ROIC/WACCN/A
WACC9.47%
CYBR Yearly LT Debt VS Equity VS FCFCYBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

CYBR has a Current Ratio of 2.31. This indicates that CYBR is financially healthy and has no problem in meeting its short term obligations.
CYBR has a better Current ratio (2.31) than 67.73% of its industry peers.
CYBR has a Quick Ratio of 2.31. This indicates that CYBR is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.31, CYBR is doing good in the industry, outperforming 68.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.31
CYBR Yearly Current Assets VS Current LiabilitesCYBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.86% over the past year.
Measured over the past 5 years, CYBR shows a small growth in Earnings Per Share. The EPS has been growing by 1.81% on average per year.
The Revenue has grown by 39.46% in the past year. This is a very strong growth!
The Revenue has been growing by 18.19% on average over the past years. This is quite good.
EPS 1Y (TTM)42.86%
EPS 3Y111.56%
EPS 5Y1.81%
EPS Q2Q%62.96%
Revenue 1Y (TTM)39.46%
Revenue growth 3Y25.78%
Revenue growth 5Y18.19%
Sales Q2Q%45.98%

3.2 Future

Based on estimates for the next years, CYBR will show a very strong growth in Earnings Per Share. The EPS will grow by 27.96% on average per year.
CYBR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.33% yearly.
EPS Next Y29.25%
EPS Next 2Y28.19%
EPS Next 3Y30.36%
EPS Next 5Y27.96%
Revenue Next Year33.83%
Revenue Next 2Y26.54%
Revenue Next 3Y24.54%
Revenue Next 5Y24.33%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYBR Yearly Revenue VS EstimatesCYBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
CYBR Yearly EPS VS EstimatesCYBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 112.51 indicates a quite expensive valuation of CYBR.
Compared to the rest of the industry, the Price/Earnings ratio of CYBR is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.03. CYBR is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 81.35, the valuation of CYBR can be described as expensive.
CYBR's Price/Forward Earnings is on the same level as the industry average.
CYBR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE 112.51
Fwd PE 81.35
CYBR Price Earnings VS Forward Price EarningsCYBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CYBR's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CYBR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 98.17
EV/EBITDA 48983.67
CYBR Per share dataCYBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CYBR does not grow enough to justify the current Price/Earnings ratio.
CYBR's earnings are expected to grow with 30.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.85
PEG (5Y)62.14
EPS Next 2Y28.19%
EPS Next 3Y30.36%

0

5. Dividend

5.1 Amount

No dividends for CYBR!.
Industry RankSector Rank
Dividend Yield N/A

CYBERARK SOFTWARE LTD/ISRAEL

NASDAQ:CYBR (8/5/2025, 8:07:21 PM)

Premarket: 405.04 0 (0%)

405.04

-3.96 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners91.51%
Inst Owner Change0.04%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap20.37B
Analysts75.35
Price Target465.79 (15%)
Short Float %3.65%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)8.25%
Max EPS beat(2)22.2%
EPS beat(4)4
Avg EPS beat(4)35.31%
Min EPS beat(4)8.25%
Max EPS beat(4)101.67%
EPS beat(8)8
Avg EPS beat(8)60.94%
EPS beat(12)12
Avg EPS beat(12)61.96%
EPS beat(16)16
Avg EPS beat(16)53.59%
Revenue beat(2)2
Avg Revenue beat(2)1.9%
Min Revenue beat(2)1.79%
Max Revenue beat(2)2.01%
Revenue beat(4)4
Avg Revenue beat(4)1.67%
Min Revenue beat(4)0.58%
Max Revenue beat(4)2.3%
Revenue beat(8)8
Avg Revenue beat(8)1.86%
Revenue beat(12)8
Avg Revenue beat(12)0.54%
Revenue beat(16)10
Avg Revenue beat(16)0.34%
PT rev (1m)1.22%
PT rev (3m)1.65%
EPS NQ rev (1m)1.24%
EPS NQ rev (3m)0.83%
EPS NY rev (1m)0.07%
EPS NY rev (3m)5.11%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 112.51
Fwd PE 81.35
P/S 16.97
P/FCF 98.17
P/OCF 91.68
P/B 8.78
P/tB 58.47
EV/EBITDA 48983.67
EPS(TTM)3.6
EY0.89%
EPS(NY)4.98
Fwd EY1.23%
FCF(TTM)4.13
FCFY1.02%
OCF(TTM)4.42
OCFY1.09%
SpS23.86
BVpS46.11
TBVpS6.93
PEG (NY)3.85
PEG (5Y)62.14
Profitability
Industry RankSector Rank
ROA -3.65%
ROE -7.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.86%
FCFM 17.29%
ROA(3y)-4.42%
ROA(5y)-3.71%
ROE(3y)-10.52%
ROE(5y)-8.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-1.54%
F-Score3
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.88
Debt/EBITDA 3078.88
Cap/Depr 14.93%
Cap/Sales 1.22%
Interest Coverage N/A
Cash Conversion 56103%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 2.31
Altman-Z 5.94
F-Score3
WACC9.47%
ROIC/WACCN/A
Cap/Depr(3y)43.07%
Cap/Depr(5y)47.67%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.86%
EPS 3Y111.56%
EPS 5Y1.81%
EPS Q2Q%62.96%
EPS Next Y29.25%
EPS Next 2Y28.19%
EPS Next 3Y30.36%
EPS Next 5Y27.96%
Revenue 1Y (TTM)39.46%
Revenue growth 3Y25.78%
Revenue growth 5Y18.19%
Sales Q2Q%45.98%
Revenue Next Year33.83%
Revenue Next 2Y26.54%
Revenue Next 3Y24.54%
Revenue Next 5Y24.33%
EBIT growth 1Y-61.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.84%
EBIT Next 3Y49.7%
EBIT Next 5YN/A
FCF growth 1Y834.66%
FCF growth 3Y49.72%
FCF growth 5Y10.39%
OCF growth 1Y553.43%
OCF growth 3Y45.88%
OCF growth 5Y10.35%